BeOne Medicines (BEIGF) Prepaid Assets (2015 - 2026)

BeOne Medicines (BEIGF) has 12 years of Prepaid Assets data on file, last reported at $190.0 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $190.0 million, up 12.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $190.0 million (up 12.97% YoY), and the FY2025 annual result was $212.8 million, up 10.28% from the prior year.
• Prepaid Assets slipped to $190.0 million in Q1 2026 per BEIGF's latest filing, from $212.8 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $1.4 billion in Q4 2022 and troughed at $168.2 million in Q1 2025.
• A 5-year average of $296.4 million and a median of $232.6 million in 2025 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 401.27% in 2022, then tumbled 80.99% in 2023.
• A 5-year view of Prepaid Assets shows it stood at $1.4 billion in 2022, then plunged by 80.99% to $257.5 million in 2023, then decreased by 25.07% to $192.9 million in 2024, then increased by 10.28% to $212.8 million in 2025, then declined by 10.7% to $190.0 million in 2026.
• Business Quant data shows BEIGF's Prepaid Assets at $190.0 million in Q1 2026, $212.8 million in Q4 2025, and $232.6 million in Q3 2025.